Related Experiment Video
Updated: Nov 5, 2025

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
Published on: September 9, 2011
Immobilization-induced symptomatic hypercalcemia treated with zoledronate in a child with a left ventricular assist
Emrah Gün1, Tanıl Kendirli1, Edin Botan1
1Department of Pediatric Intensive Care, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.
Abstract:
Differential diagnosis of hypercalcemia in children includes confirmation of hyperthyroidism, infection, inflammatory processes, and malignant tumors. Immobilization-induced hypercalcemia is rare in healthy individuals, although it can occur in adolescent males, especially after fracture. Immobility can cause increased skeletal calcium release and hypercalcemia, and this condition is also known as resorptive hypercalcemia. We present a case of a 10-year-old adolescent girl with advanced heart failure who underwent implantation with a HeartMate 3 left ventricular assist device. She had symptoms of abdominal pain, vomiting, and constipation on the fifth month of hospitalization. She subsequently developed immobilization-induced symptomatic hypercalcemia (serum calcium, 12.1 mg/dL; corrected calcium 12.8 mg/dL; parathormone, 1.9 pg/mL; calcium/creatinine ratio in spot urine, 1.21). However, hypercalcemia is uncommon in children with advanced heart failure. Bisphosphonate therapy was initiated because our patient did not respond to hydration and furosemide treatment, and she had persistent abdominal pain, vomiting, and constipation. The patient's complaints were resolved on the second day after administrating bisphosphonate, and hypercalcemia did not recur.
Related Concept Videos
Skeleton and Calcium Homeostasis
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Mitral Stenosis III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease IV: Nursing Management
Urinary Tract Calculi III: Medical Management

